Gentamicin is an
antibiotic effective against Gram-negative
infection, whose clinical use is limited by its nephrotoxicity.
Oxygen free radicals are considered to be important mediators of
gentamicin-mediated nephrotoxicity, but the exact nature of the radical in question is not known with certainty. We have investigated the potential role of
superoxide in
gentamicin-induced renal toxicity by using
M40403, a low molecular weight synthetic
manganese containing
superoxide dismutase mimetic, which selectively removes
superoxide. Administration of
gentamicin at 100 mg/kg, s.c. for 5 days to rats induced a marked
renal failure, characterised by a significant decrease in
creatinine clearance and increased plasma
creatinine levels, fractional excretion of
sodium,
lithium, urine gamma glutamyl
transferase (gamma GT) and daily urine volume. A significant increase in kidney
myeloperoxidase activity and lipid peroxidation was also observed in
gentamicin-treated rats.
M40403 (10 mg/kg, i.p. for 5 days) attenuated all these parameters of damage. Immunohistochemical localisation demonstrated
nitrotyrosine formation and
poly(ADP-ribose)
synthetase (PARS) activation in the proximal tubule of
gentamicin-treated rats. Renal histology examination confirmed tubular
necrosis.
M40403 significantly prevented
gentamicin-induced
nitrotyrosine formation,
poly(ADP-ribose)
synthetase activation and tubular
necrosis. These results confirm our hypothesis that
superoxide anions play an important role in
gentamicin-mediated nephropathy and support the possible clinical use of low molecular weight synthetic
superoxide dismutase mimetics in those conditions that are associated with over production of
superoxide.